Strategy for construction of live picornavirus vaccines
- PMID: 2838985
- DOI: 10.1016/s0264-410x(88)80015-x
Strategy for construction of live picornavirus vaccines
Abstract
A number of recombinant viruses between the virulent Mahoney and the attenuated Sabin 1 strains of type 1 poliovirus were constructed in vitro using their infectious cDNA clones. Monkey neurovirulence tests on these recombinant viruses revealed that the surface structure of the virion particle had a little correlation with the neurovirulent phenotype, and that the strong neurovirulence determinant(s) resided in the 5' noncoding sequence. These results in turn led to two possible strategies for constructing live attenuated picornavirus strains. One is to use the Sabin 1 strain as a vector carrying foreign antigenicities. The other is the construction of the attenuated picornaviruses by introducing mutations into the 5' noncoding sequences. The antigenicity of the Sabin 1 strain was successfully changed to those of other poliovirus serotypes without loss of vaccine quality. Furthermore, it was proved that introduction of deletion mutation into the 5' noncoding sequence of genomes of the Sabin 1 and Mahoney strains resulted in construction of viruses with a less neurovirulent phenotype.
Similar articles
-
Development of candidates for new type 2 and type 3 oral poliovirus vaccines.Dev Biol Stand. 1993;78:141-8. Dev Biol Stand. 1993. PMID: 8388824
-
A recombinant virus between the Sabin 1 and Sabin 3 vaccine strains of poliovirus as a possible candidate for a new type 3 poliovirus live vaccine strain.J Virol. 1988 Aug;62(8):2828-35. doi: 10.1128/JVI.62.8.2828-2835.1988. J Virol. 1988. PMID: 2839704 Free PMC article.
-
Determinants in the 5' noncoding region of poliovirus Sabin 1 RNA that influence the attenuation phenotype.J Virol. 1989 Mar;63(3):1302-9. doi: 10.1128/JVI.63.3.1302-1309.1989. J Virol. 1989. PMID: 2536835 Free PMC article.
-
[Molecular genetic analysis of poliovirus infection].Yakugaku Zasshi. 1989 Sep;109(9):622-35. doi: 10.1248/yakushi1947.109.9_622. Yakugaku Zasshi. 1989. PMID: 2481725 Review. Japanese.
-
Potential use of poliovirus as a vector.Biologicals. 1993 Dec;21(4):371-7. doi: 10.1006/biol.1993.1098. Biologicals. 1993. PMID: 8024753 Review.
Cited by
-
Translational Control of the Picornavirus Phenotype.Mol Biol. 2001;35(4):591-599. doi: 10.1023/A:1010531228348. Mol Biol. 2001. PMID: 32214465 Free PMC article.
-
Virus-host coevolution in a persistently coxsackievirus B3-infected cardiomyocyte cell line.J Virol. 2011 Dec;85(24):13409-19. doi: 10.1128/JVI.00621-11. Epub 2011 Oct 5. J Virol. 2011. PMID: 21976640 Free PMC article.
-
Myeloma xenograft destruction by a nonviral vector delivering oncolytic infectious nucleic acid.Mol Ther. 2011 Jun;19(6):1041-7. doi: 10.1038/mt.2011.68. Epub 2011 Apr 19. Mol Ther. 2011. PMID: 21505425 Free PMC article.
-
Protection against lethal encephalomyocarditis virus infection in the absence of serum-neutralizing antibodies.J Virol. 1998 Oct;72(10):8052-60. doi: 10.1128/JVI.72.10.8052-8060.1998. J Virol. 1998. PMID: 9733845 Free PMC article.
-
Picornavirus-specific CD4+ T lymphocytes possessing cytolytic activity confer protection in the absence of prophylactic antibodies.J Virol. 1995 Aug;69(8):4914-23. doi: 10.1128/JVI.69.8.4914-4923.1995. J Virol. 1995. PMID: 7609060 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
